{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Txsyn%20Int.%20LLC","name":"Txsyn Int. LLC","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-09-29T14:54:31.034Z"},"count":1,"matches":[{"id":"5e643c518e45bcdf","posted_date":"2024-08-13","letter_issue_date":"2024-07-24","company_name":"Txsyn Int. LLC","issuing_office":"Division of Human and Animal Food Operations West III","subject":"CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/5e643c518e45bcdf"}]}